Of the patients with a PSA of 1.01 ≤ 2 ng/mL and distant metastases, only 9/24 (37.5%) received locally applicable treatment methods, considerably fewer patients than in the groups with lower PSA values, which supports the assumption of a lower tumor burden in the other groups in the sense of an oligometastatic situation. Here, KLK3 is linked to neoplasm.